MBIO: Mustang Bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.30
Enterprise Value ($M) -3.54
Book Value ($M) -3.87
Book Value / Share -1.58
Price / Book -0.85
NCAV ($M) -4.58
NCAV / Share -1.86
Price / NCAV -0.72

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.08
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.68
Current Ratio 0.68

Balance Sheet (mrq) ($M)
Current Assets 8.61
Assets 9.31
Liabilities 13.18
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -12.55
Net Income -15.75
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -11.41
Cash from Investing 0.00
Cash from Financing 11.27

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-02 13D/A Fortress Biotech, Inc. 7.90 -96.97
02-14 13G Armistice Capital, Llc
02-11 13G Intracoastal Capital, Llc 9.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 12,214 32,023 38.14
2025-04-16 2,996 8,466 35.39
2025-04-15 5,453 20,768 26.26
2025-04-14 5,740 16,687 34.40

(click for more detail)

Similar Companies
LQDA – Liquidia Corporation LSTA – Lisata Therapeutics, Inc.
LTRN – Lantern Pharma Inc. MBRX – Moleculin Biotech, Inc.
MEIP – MEI Pharma, Inc.


Financial data and stock pages provided by
Fintel.io